Lucentis

  • prescription drug

Description

Lucentis manufactured by Novartis (ranibizumab injection) is a prescription drug used in the treatment of patients with diabetic macular edema (DME) wet age-related macular degeneration (wAMD), and macular edema following retinal vein occlusion (RVO).

To buy the medicine or know its price, contact us

Manufacturer: Novartis

Additional Information

Lucentis is a prescription medication given by injection into the eye, and it has side effects. Lucentis is not for everyone. You should not use lucentis if you have an infection in or around the eye or are allergic to lucentis or any of its ingredients.

Some  patients have serious side effects related to the injection. These include serious infections inside the eye, detached retinas, and cataracts. Other uncommon serious side effects include inflammation inside the eye and increased eye pressure. These side effects can make your vision worse. Some patients have had increased eye pressure before and within 1 hour of an injection. Your eye doctor should check your eye pressure and eye health during the week after your LUCENTIS injection.

Uncommonly, patients have had serious, sometimes fatal, problems related to blood clots, such as heart attacks or strokes.

If your eye becomes red, sensitive to light, or painful, or if you have a change in vision, call or visit your eye doctor right away.

Side Effects

The most common eye-related side effects are increased redness in the white of the eye, eye pain, small specks in vision, and increased eye pressure. The most common non–eye-related side effects are nose and throat infections, headache, lung/airway infections, and nausea.

Pack Size